| 标题 |
Correspondence on ‘EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease–modifying antirheumatic drugs: 2025 update’ by Smolen et al and ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial)’ by Imai et al |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of the Rheumatic Diseases 作者:Suhail Aamar 出版日期:2026-09-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)